Physiotherapy Management of Guillain-Barré Syndrome in a Tertiary Hospital in South-South Nigeria: A Case Report.

Abstract

Background: Guillain-Barré Syndrome (GBS) is a potentially life-threatening post infectious disease characterized by rapidly progressive, symmetrical weakness of the extremities. It can cause life-threatening complications, particularly if the breathing muscles are affected or if there is dysfunction of the autonomic nervous system. Case Presentation: This is a case report of Physiotherapy management of a 51-year old female patient with Guillain-Barré Syndrome (GBS). Patient was referred from the neurology unit, department of Internal Medicine, University of Port Harcourt Teaching Hospital (UPTH) to the neurology clinic of the physiotherapy department, UPTH as a case GBS after series of investigations. Appropriate physiotherapy intervention was given for a period of 36 weeks after a thorough assessment of the patient. The Guillain-Barre Syndrome Disability Score was used to assess the overall functional status of the patient while the Oxford Muscle Grading Scale was used to assess for muscle strength. The Numerical Pain Rating Scale (NPRS) was used to assess the level of pain in the limbs while the Berge Balance Scale (BBS) was used to assess the patient’s balance. The case report was presented in line with the CARE: Case Report Guideline for case reports. All ethical procedures were followed. Treatment outcome: Treatment outcome revealed that the Guillain-Barré Syndrome Disability Score reduced from 4 to 2 while that of Berg Balance Scale increased from 3 to 42 after 36 weeks of intervention. Pain level on range of motion of the limbs based on the Numerical Pain Rating Scale reduced from 6/10 to 1/10 on the upper limb and from 8/10 to 2/10 on the lower limbs. Conclusion: Physiotherapy is effective in the management of  patients with Guillain-Barré Syndrome. Early referral to Physiotherapy is key to pain management, balance control and overall functional status of the patients.

Keywords:

Physiotherapy Management, Guillain-Barre syndrome, South-South Nigeria, Case Report

References

World Health Organization, 2016 https://www.who.int/news-room/fact-sheets/detail/guillain-barr%C3%A9-syndrome.

Nguyen, T. P., & Taylor, R. S. Guillain Barre Syndrome. In StatPearls [Internet]. StatPearls Publishing; 2022.

Expósito, J., Carrera, L., Natera, D., Nolasco, G., Nascimiento, A., & Ortez, C. (2022). Síndrome de Guillain-Barré y otras neuropatías autoinmunes: tratamiento actual [Guillain-Barré syndrome and other autoimmune neurophaties: current therapy]. Medicina, 82 Suppl 3, 82–88.

Hughes, R. A., Swan, A. V., & Van Doorn, P. A. (2014). Intravenous immunoglobulin for Guillain‐Barré syndrome. Cochrane Database of Systematic Reviews, (9).

Laparidou, D., Curtis, F., Akanuwe, J., Jackson, J., Hodgson, T. L., & Siriwardena, A. N. Patients’ experiences and perceptions of Guillain-Barré syndrome: A systematic review and meta-synthesis of qualitative research. Plos one, 2021; 16(2), e0245826.

Bersano, A., Carpo, M., Allaria, S., Franciotta, D., Citterio, A., & Nobile-Orazio, E. (2006). Long term disability and social status change after Guillain–Barré syndrome. Journal of neurology, 253, 214-218.

Hooks Jr, J. D. (2015). Understanding the patient’s recalled experience of an acute episode of Guillain-Barre’syndrome: A qualitative descriptive study (Doctoral dissertation, University of Kansas).

Dubey, D., Kapotic, M., Freeman, M., Sawhney, A., Rojas, J. C., Warnack, W., & Vernino, S. (2016). Factors contributing to delay in diagnosis of Guillain‐Barré syndrome and impact on clinical outcome. Muscle & Nerve, 53(3), 384-387.

Forsberg, A., Ahlström, G., & Holmqvist, L. W. (2008). Falling ill with Guillain‐Barré syndrome: patients’ experiences during the initial phase. scandinavian Journal of Caring sciences, 22(2), 220-226.

Leonhard, S. E., Mandarakas, M. R., Gondim, F. A., Bateman, K., Ferreira, M. L., Cornblath, D. R., ... & Jacobs, B. C. (2019). Diagnosis and management of Guillain–Barré syndrome in ten steps. Nature Reviews Neurology, 15(11), 671-683.

Van den Berg, B., Walgaard, C., Drenthen, J., Fokke, C., Jacobs, B. C., & Van Doorn, P. A. (2014). Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews Neurology, 10(8), 469-482.

Nyati KK, Nyati R. Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update. BioMed research international. 2013 Oct;2013.

Shahrizaila, N., Lehmann, H. C., & Kuwabara, S. (2021). Guillain-Barré syndrome. The lancet, 397(10280), 1214-1228.

Donofrio, P. D. (2017). Guillain-Barré Syndrome. CONTINUUM: Lifelong Learning in Neurology, 23(5), 1295-1309.

Ansar V, Valadi N. Guillain-Barré syndrome. Primary Care: Clinics in Office Practice. 2015 Jun 1;42(2):189-93.

Panesar K: Guillain-barré syndrome. Neurology. 2014, 39:35-8

Rahimi K: Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports . Neurol Sci. 2020, 41:3149-56. 10.1007/s10072-020-04693-y

Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014 Jan 1; 137(1):33-43.

Nehal S, Manisha S. Role of physiotherapy in Guillain Barre Syndrome: A narrative review. Int J Heal. Sci. & Research. 2015;5(9):529.

Gopalakrishna KN, Ramesh VJ. Management of guillain-barré syndrome. Journal of Neuroanaesthesiology and Critical Care. 2019 Jun; 6(02):160-6.

Hughes RAC, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2012; 8.

van Doorn PA. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS). La Presse Médicale. 2013 Jun 1;42(6):e193-201.

Simatos Arsenault N, Vincent PO, Yu BH, Bastien R, Sweeney A. Influence of exercise on patients with Guillain-Barré syndrome: a systematic review. Physiotherapy Canada. 2016;68(4):367-76.

Rajabally YA, Uncini A. Outcome and its predictors in Guillain–Barré syndrome. Journal of Neurology, Neurosurgery & Psychiatry. 2012 Jul 1; 83(7):711-8.

Berisavac I, Arsenijevic M, Bozovic I, Mladenovic B, Kacar A, Tamas OS, Petrovic M, Stojanovic M, Vujovic B, Martic V, Jovanovic D. Disability and quality of life in Guillain-Barré syndrome–Longitudinal study. Journal of Clinical Neuroscience. 2020 Aug 1; 78:185-8.

Berg k, Wood-Dauphinee S. The Balance Scale: reliability assessment with elderly residents and patients with acute stroke. Scandinavian Journal of Rehabilitation Medicine 1995; 27(1): 27-36.

Oti IK, Nwaedozie OC, Ayerite AB, Anyama EU. A Case Report of Limb Dystonia Management in a Nigerian Hospital: Physiotherapy Perspective.

Connors C, McNeill S, Hrdlicka HC. Occupational and physical therapy strategies for the rehabilitation of COVID-19-related Guillain-Barré syndrome in the long-term acute care hospital setting: case report. JMIR rehabilitation and assistive technologies. 2022 Feb 10;9(1):e30794.

Prada V, Massa F, Salerno A, Fregosi D, Beronio A, Serrati C, Mannironi A, Mancardi G, Schenone A, Benedetti L. Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study. Neurological Sciences. 2020 Feb; 41:321-7.

Orsini M, de Freitas MR, Presto B, Mello MP, Reis CH, Silveira V, Silva JG, Nascimento OJ, Leite MA, Pulier S, Sohler MP. Guideline for neuromuscular rehabilitation in Guillain-Barre Syndrome: what can we do?. Revista Neurociências. 2010 Dec 31;18(4):572-80.

Bölükbaşi F, Ersen G, Gündüz A, Karaali-Savrun F, Yazici S, Uzun N, Akalin MA, Kiziltan ME. Guillain-barré syndrome and its variants: Clinical course and prognostic factors. Archives of Neuropsychiatry. 2019 Mar; 56(1):71.

Park SH, Kim NH. Early prediction factors of poor outcome in Guillain-Barre syndrome. Soonchunhyang Medical Science. 2016 Dec 31; 22(2):79-82.

Gawande I, Akhuj A, Samal S, Gawande IV I. Effectiveness of Physiotherapy Intervention in Guillain Barre Syndrome: A Case Report. Cureus. 2024 Jan 10;16(1).

Sulli S, Scala L, Berardi A, Conte A, Baione V, Belvisi D, Leodori G, Galeoto G. The efficacy of rehabilitation in people with Guillain-Barre syndrome: a systematic review of randomized controlled trials. Expert Review of Neurotherapeutics. 2021 Apr 3; 21(4):455-61.